Factor-VIII-activity
Material: | 1 ml citrate plasma, frozen (Stability in citrate plasma at 4°C – 8°C: 4 hours) |
Methods: | Koagulometrie → Koagulometrie | Reference range | 50% – 150% Children: Please refer to findings report |
Indication |
|
Please note | A normal PTT value does not rule out subhemophilia A. Patients with blood group 0 show lower values (between 40 % and 80 %). Guide to interpretation: > 150 %: Acute phase reaction, permanently increased activities can be a risk factor for thromboembolic event. 50 % – 150 %: normal hemostasis 25 % – 50 %: Subhemophilia A or von-Willebrand-syndrome, slightly increased risk for bleeding, minor surgery with low risk of bleeding are possible without substitution. 5 % – 25 %: mild hemophilia A or von-Willebrand-syndrome, increased bleeding tendency 1 % – 5 %: moderate hemophilia A or von-Willebrand-syndrome type 3, spontaneous bleeding possible < 1 %: severe hemophilia A, often spontaneous bleeding (especially intraarticular bleeding)
CAUTION: An acute phase reaction can disguise mild hemophilia or subhemophilia.
For differential diagnosis between hemophilia A and von-Willebrand-syndrome both the von-Willebrand-factor antigen and von-Willebrand-factor activity should be evaluated for the assessment of bleeding tendency. |
Accredited | ja |
More Results for the letter F
- Factor II activity (FACT01)
- Prothrombin
- Factor II mutation (FACT02)
- Prothrombin mutation G20210A
- Factor IX activity (FACT11)
- Factor V activity (FACT03)
- Factor V mutation Leiden (FACT04)
- Mutation: G1691A
- Factor VII activity (FACT05)
- Factor VIII activity (FACT06)
- Factor VIII inhibitor (FACT10)
- Factor VIII ristocetin cofactor (von Willebrand factor activity) (FACT08)
- vWF:activity
- Factor VIII von Willebrand factor antigen (FACT07)
- vWF:Ag
- Factor VIII von Willebrand multimers (FACT09)
- Factor X activity (FACT12)
- Factor XI activity (FACT13)
- Factor XII activity (FACT14)
- Hageman-Factor
- Factor XIII activity (FACT15)
- Syn.: fibrin stabilising factor
- Factor–II–activity (FAK2)
- Prothrombin
- Factor-II-mutation (FAK2GM)
- Prothrombin mutation G20210A
- Factor-IX-activity (FAK9)
- Factor-V-activity (FAK5)
- Factor-V-mutation Leiden (FAK5GM)
- Mutation: G1691A
- Factor-VII-activity (FAK7)
- Factor-VIII-activity (FAK8)
- Factor-VIII-inhibitor (FAK8IN)
- Bethesda assay
- Factor-X-activity (FAK10)
- Factor-XI-activity (FAK11)
- Factor-XII-activity (FAK12)
- Hageman factor
- Factor-XIII-activity (FAK13)
- Fibrin-stabilizing factor
- Fasciola hepatica (FASCI, FASCG)
- Common liver fluke
- Fat, total in stool (FETT1)
- Fatty acids, long-chained (LAFS)
- LCFA